The combination of sacubitril and valsartan appeared superior to enalapril in the first randomized trial to generate high-quality evidence to support a drug treatment specifically for patients with ...
Hosted on MSN
Sacubitril/valsartan shows benefit over enalapril in heart failure caused by Chagas disease
In patients with heart failure (HF) caused by Chagas disease, sacubitril/valsartan was superior to enalapril for the composite primary endpoint, predominantly driven by a significant reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback